Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a systematic review
N Molazadeh, G Bose, I Lotan… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
has various similarities with AQP4-IgG-seropositive Neuromyelitis Optica Spectrum Disorder …
has various similarities with AQP4-IgG-seropositive Neuromyelitis Optica Spectrum Disorder …
Optic perineuritis
G Saitakis, BK Chwalisz - Current Opinion in Ophthalmology, 2022 - journals.lww.com
Unlike optic nerve, OPN is not typically self-limited without treatment. High-dose oral
corticosteroids are the mainstay of treatment in OPN. The initiation of therapy usually causes …
corticosteroids are the mainstay of treatment in OPN. The initiation of therapy usually causes …
The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature
G Schirò, S Iacono, G Salemi… - Expert Review of …, 2024 - Taylor & Francis
Introduction Myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease
(MOGAD) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (AQP4+)-IgG …
(MOGAD) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (AQP4+)-IgG …
Tocilizumab treatment in MOGAD: a case report and literature review
G Schirò, S Iacono, M Andolina, A Bianchi… - Neurological …, 2024 - Springer
Myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD) is an
autoimmune demyelinating disorder of the central nervous system (CNS) which usually …
autoimmune demyelinating disorder of the central nervous system (CNS) which usually …
MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple …
J Tom Mishael, S Sandeep, A George, B Philip… - Egyptian Journal of …, 2023 - Springer
Background Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a novel
inflammatory demyelinating disease of the central nervous system. This study aims to …
inflammatory demyelinating disease of the central nervous system. This study aims to …
Efficacy of tocilizumab in highly relapsing MOGAD with an inadequate response to intravenous immunoglobulin therapy: A case series
YR Kang, KH Kim, JW Hyun, SH Kim, HJ Kim - Multiple Sclerosis and …, 2024 - Elsevier
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is
an inflammatory disease affecting the central nervous system that may require long-term …
an inflammatory disease affecting the central nervous system that may require long-term …
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated by Pachymeningitis: A Case Report
SM Khaladkar, PP KirdatPatil, A Dhande, NA Jhala - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare
autoimmune disorder that primarily affects the central nervous system (CNS). We present a …
autoimmune disorder that primarily affects the central nervous system (CNS). We present a …